Snai2 was found to associate with the gender, histological variants, BRAF/RAS phenotype, and lymph node metastases, while Zeb1 was found to be associated significantly with the histological variants, BRAF phenotype, tumor size, and disease recurrences. This evidence concerns the gene ZEB1 and neoplasm.